tiprankstipranks
Trending News
More News >
Pacira Pharmaceuticals (PCRX)
NASDAQ:PCRX
US Market

Pacira Pharmaceuticals (PCRX) Technical Analysis

Compare
375 Followers

Technical Sentiment

Overall Consensus
Strong Buy
15Bullish
5Neutral
2Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Pacira Pharmaceuticals’s (PCRX) Moving Averages Convergence Divergence (MACD) indicator is 0.82, suggesting Pacira Pharmaceuticals is a Sell.
Pacira Pharmaceuticals’s (PCRX) 20-Day exponential moving average is 25.07, while Pacira Pharmaceuticals’s (PCRX) share price is $21.85, making it a Buy.
Pacira Pharmaceuticals’s (PCRX) 50-Day exponential moving average is 24.30, while Pacira Pharmaceuticals’s (PCRX) share price is $21.85, making it a Buy.

Pacira Pharmaceuticals (PCRX) Pivot Points

Dec 20, 2025, 06:24 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
24.21
24.95
25.42
26.16
26.63
27.37
27.84
Fibonacci
24.95
25.42
25.70
26.16
26.63
26.91
27.37
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Pacira Pharmaceuticals (PCRX) Moving Averages

Dec 20, 2025, 06:24 PM
Period
Simple
Exponential
MA5
26.33Buy
26.16Buy
MA10
25.80Buy
25.76Buy
MA20
24.74Buy
25.07Buy
MA50
23.42Buy
24.30Buy
MA100
24.37Buy
24.17Buy
MA200
24.40Buy
24.09Buy
Pacira Pharmaceuticals’s (PCRX) 10-Day exponential moving average is 25.76, while Pacira Pharmaceuticals’s (PCRX) share price is $21.85, making it a Buy.
Pacira Pharmaceuticals’s (PCRX) 100-Day exponential moving average is 24.17, while Pacira Pharmaceuticals’s (PCRX) share price is $21.85, making it a Buy.
Pacira Pharmaceuticals’s (PCRX) stock price is $21.85 and Pacira Pharmaceuticals’s (PCRX) 50-day simple moving average is 23.42, creating a Buy signal.
Pacira Pharmaceuticals’s (PCRX) stock price is $21.85 and Pacira Pharmaceuticals’s (PCRX) 100-day simple moving average is 24.37, creating a Buy signal.
Pacira Pharmaceuticals’s (PCRX) stock price is $21.85 and Pacira Pharmaceuticals’s (PCRX) 200-day simple moving average is 24.40, creating a Buy signal.

Pacira Pharmaceuticals (PCRX) Technical Indicators

Dec 20, 2025, 06:24 PM
Name
Value
Implied Action
RSI (14)
64.94
Neutral
STOCH (9,6)
73.68
Neutral
STOCHRSI (14)
76.43
Neutral
MACD (12,26)
0.82
Sell
ADX (14)
30.69
Neutral
Williams %R
-21.99
Buy
CCI (14)
101.82
Sell
ATR (14)
1.07
-
Ultimate Oscillator
51.35
Neutral
ROC
11.18
Buy
Pacira Pharmaceuticals’s (PCRX) Relative Strength Index (RSI) is 64.94, creating a Neutral signal.
Pacira Pharmaceuticals’s (PCRX) Trend Strength Indicator (ADX) is 30.69, creating a Neutral signal.
Pacira Pharmaceuticals’s (PCRX) Commodity Channel Index (CCI) is 101.82, creating a Sell signal.
Pacira Pharmaceuticals’s (PCRX) Price Rate of Change (ROC) is 11.18, creating a Buy signal.

FAQ

Is PCRX a Buy, Hold, or Sell?
Based on PCRX’s technical indicators, PCRX is a Strong Buy.
    What is PCRX’s RSI (14)?
    PCRX’s RSI (14) is 64.94, which suggests PCRX is a Neutral.
      What is PCRX’s MACD?
      PCRX’s MACD is 0.82, which suggests PCRX is a Sell.
        What is PCRX’s 5-day moving average?
        PCRX’s 5-day moving average is 26.33, which suggests PCRX is a Buy.
          What is PCRX’s 20-day moving average?
          PCRX 20-day moving average is 24.74, which suggests PCRX is a Buy.
            What is PCRX’s 50-day moving average?
            PCRX’s 50-day moving average is 23.42, which suggests PCRX is a Buy.
              What is PCRX’s 200-day moving average?
              PCRX’s 200-day moving average is 24.40, which suggests PCRX is a Buy.
                What is PCRX’s Williams % R (14)?
                PCRX’s Williams % R (14) is -21.99, which suggests PCRX is a Buy.
                  What is PCRX’s CCI (14)?
                  PCRX’s CCI (14) is 101.82, which suggests PCRX is a Sell.